Susan Hasty, Publisher
Table of Contents . . . January 16th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
AIDS and HIV Vaccine - Interleukins Can Be Effective Adjuvants For Mucosal Administration
Vector Development - Researchers Develop New Method Of Delivery Vaccines
AIDS and HIV Vaccine - Nef-Deleted Vaccine Strain Replicates In CD4 Cells
Malaria - Vaccine May Protect Against Mosquito-borne Disease
Vaccine Development - Cross-Reactive Memory Cells Recognize HCV Peptides After Influenza Exposure
Vaccine Development - New Vaccine Wards Off Recurring Urinary Tract Infections
AIDS Therapies - Structured Treatment Interruptions Evaluated In HIV Patients
Adjuvants - Antigenics Receives Milestone Payment from Elan Corp. for QS-21
Anthrax Vaccine - America's Only Manufacturer Seeks FDA Approval To Ship
Antibody Therapy - Alexion Completes Phase I Dermatomyositis Pilot Safety Study
Bioterrorism - Army Anthrax Lab Security Called Lax
Bioterrorism - Florida Media Company Employees Offered Anthrax Vaccine; Few Take
Bioterrorism - Israel Has Anthrax Vaccine, Could Immunize Entire Population
Bioterrorism - Suddenly, Refrigerators For Vaccines Very Popular
Cancer Gene Therapy - Drug Candidate INGN 201 Looks Promising
Ethics - General Accounting Office Probes Tainted Medical Research
HIV Vaccine - NIAID, Merck To Collaborate On HIV Vaccine Development
Human Papillomavirus - Second Phase II Clinical Trial Of MVA-HPV-IL2 Vaccine Initiated
Immunology - Researchers Illuminate How The Body Handles Inflammation
Lung Cancer - Clinical Data From Phase I/II GVAX Vaccine Trial Updated
Malaria - Immune Response Enhancer Improves Vaccine
Research - Vical and Aventis Restructure Agreements
Ruebella - Measles Nearly Eradicated In The West, CDC Says
Travelers Diseases - Antex Launches Phase I Human Trial for Vaccine
Type 1 Diabetes - Adeno-Associated Virus Gene Transfer Could Prevent Several Disorders
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.